首页> 外文期刊>Клиничесκая лабораторная диагностиκа >Screening as a method for determining the serum level of nitric oxide metabolites
【24h】

Screening as a method for determining the serum level of nitric oxide metabolites

机译:作为确定一氧化氮代谢物血清水平的方法

获取原文
获取原文并翻译 | 示例
       

摘要

The paper describes a modified method for determining stable nitric oxide (NO) metabolites, which permits one-stage assay of total nitrates and nitrites after blood serum deproteinization. The assay is based on the simultaneous reduction of nitrates and nitrites by vanadium chloride and by diazotization with subsequent stimulation of tinting whose rate is spectrophotometrically estimated at 540 nm. Assay of 100 microl of the deproteinized serum is made, by using a flat-bottomed 96-well plate. The sensitivity of the method is 1.7 microM. The concentration of total NO metabolites detected by the assay in the sera of volunteers ranged from 37.2 to 87.2 microM. It is suggested that the above modified assay may be used in clinical practice for the measurement of the concentrations of terminal NO metabolites since they are early markers of vascular endothelial NO-forming dysfunction.
机译:本文描述了一种用于确定稳定的一氧化氮(NO)代谢物的修饰方法,其允许在血清脱蛋白后的总硝酸盐和亚硝酸盐的一级测定。 该测定基于氯化钒同时减少硝酸盐和亚硝酸盐,并通过重氮化随后刺激着色刺激,其速率在540nm处被分光光度估计。 通过使用平底96孔板制造100μm脱蛋白血清的测定。 该方法的灵敏度为1.7 microm。 志愿者血清中的测定中检测到的总量没有代谢物的浓度范围为37.2至87.2微米。 建议,上述修饰的测定可以用于临床实践中,用于测量终端的浓度,因为它们是血管内皮无成型功能障碍的早期标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号